Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides

This publication has 30 references indexed in Scilit:

• Synthesis, Conjugation, and Radiolabeling of a Novel Bifunctional Chelating Agent for ²²⁵Ac Radioimmunotherapy Applications
  Bioconjugate Chemistry, 2000
• Spectrophotometric method for determination of bifunctional macrocyclic ligands in macrocyclic ligand–protein conjugates
  Nuclear Medicine and Biology, 1999
• Comparison of 225actinium chelates: tissue distribution and radiotoxicity
  Nuclear Medicine and Biology, 1999
• Improved in Vivo Stability of Actinium-225 Macrocyclic Complexes
  Journal of Medicinal Chemistry, 1999
• Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II Study
  Gynecologic Oncology, 1997
• Evaluation of a new DTPA-derivative chelator: Comparative biodistribution and imaging studies of 111In-labeled B3 monoclonal antibody in athymic mice bearing human epidermoid carcinoma xenografts
  Nuclear Medicine and Biology, 1993
• The feasibility of 225 Ac as a source of ??-particles in radioimmunotherapy
  Nuclear Medicine Communications, 1993
• Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labelling of monoclonal antibodies with the bismuth-212 α-particle emitter
  Journal of the Chemical Society, Perkin Transactions 1, 1992
• Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies
  Inorganic Chemistry, 1986
• Metabolic Characteristics Within a Chemical Family
  Health Physics, 1959